Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Unknown × pertuzumab × Clear all

Phase

Phase 2 13 Phase 3 2 Phase NA 1 Phase 1/2 1 Phase 1 1

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Blood Specimen Collection 49 Exercise 48 Radiotherapy 42 Radiosurgery 33 Standard of Care 30 Drug Therapy 30 Surgical Procedures, Operative 26 Magnetic Resonance Spectroscopy 26 Acupuncture Therapy 24 Biopsy 23 Cisplatin 22 Cyclophosphamide 21 Magnetic Resonance Imaging 19 Laparoscopy 19 Endoscopic Mucosal Resection 19 Control Groups 18 Radiofrequency Ablation 17 Saline Solution 16 camrelizumab 15 Surveys and Questionnaires 15 Propofol 15 Metformin 15 Preoperative Exercise 14 Fluorouracil 14 Cytarabine 14 anlotinib 13 Radiotherapy, Intensity-Modulated 13 Early Intervention, Educational 13 apatinib 12 Neoadjuvant Therapy 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05656079 2022-12-19

easy laugh

Shanghai Pudong Hospital

Phase NA Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡